Sitemap
-
About PHARMAC
-
Your guide to PHARMAC
- Introduction to PHARMAC
- PHARMAC history
- Our place in the health system
- Making funding decisions
- Contract negotiation
- Generic and biosimilar medicines
- Managing medicine supply
- The combined pharmaceutical budget (CPB)
- Medicine targeting
- Access and responsible use
- Clinical advice
- Engaging with consumers
- Getting involved in PHARMAC's decision-making
- The Pharmaceutical Schedule
- Medical devices
- Our history
- Our people
- Committees
- Panels
- PHARMAC's performance
- Operating policies and procedures
-
Year in review 2017
- 2017 year highlights
- Chief Executive's summary
- The vaccines story
- Impact on access to cancer medicines
- Bold goal - equity
- Bold goal - medical devices
- Bold goal - systems
- Better value in hospitals
- Community engagement
- Pricing in the limelight
- Covering the many, caring for the few
- Top 20 therapeutic groups
- Top 20 companies by gross spend
- Top 20 medicines by prescriptions
- Top 20 medicines by spend
- Freeing up resources for DHB hospitals
- Therapeutic group summary
- Infections - antivirals
- Infections - antibacterials
- Cancer medicines
- Vaccines
- Respiratory
- Autoimmune conditions
- Heart disease
- Mental health
- Strategies
-
Your guide to PHARMAC
-
Medicines
-
How medicines are funded
- New funding applications
- Factors for consideration
-
Economic analysis
-
Prescription for Pharmacoeconomic Analysis
- 1 Background
- 2 Health Economic Analysis at PHARMAC
- 3 Economic Modelling and Scope of Analysis
- 4 Evidence for Relative Clinical Effect
- 5 Transformation of Evidence
- 6 Estimating Health Benefits
- 7 Estimating Costs
- 8 Discounting
- 9 Results of Cost-Utility Analysis
- 10 Sensitivity Analysis
- 11 Presentation of Data and Results
- Appendix 1 – PHARMAC Guidelines for Reviewing CUAs
- Appendix 2 – Discounting
- References
-
Prescription for Pharmacoeconomic Analysis
- Prioritisation
- Having your say
- Medicines for rare disorders
- The annual tender
- Medicines information
-
My medicine has changed
- Alprazolam
- Anastrozole
- Diabetes meters
- Emergency contraceptive pill
- Escitalopram
- Head lice treatment
- Hepatitis C treatments
- Leflunomide
- Metoprolol
- Nicotine replacement therapy
- Omeprazole
- Prednisolone eye drops
- Sumatriptan injections
- Sumatriptan tablets
- Travoprost eye drops
- Venlafaxine
- Pulmonary arterial hypertension treatments
- Your health
- Hospital pharmaceuticals
- New medicines
-
How medicines are funded
- Hospital devices
- News
- Te Whaioranga
- Pacific
- Tools & resources
- Information for…
Last updated: 2 November 2015
